Application of indacaterol in the treatment of colorectal cancer
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- ZHEJIANG UNIV
- Publication Date
- 2019-11-01
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of molecular biology, in particular to the field of tumor treatment, and relates to a series of therapeutic drugs screened according to markers specifically expressed in colorectal cancer. Specifically, the present invention utilizes gene alternative splicing for the first time to screen a drug for treating colorectal cancer, specifically, the drug is Indacaterol. Background technique
[0002] Colorectal cancer is one of the malignant tumors that poses a great threat to human survival and health in the world today, ranking third in the cancer death spectrum in western developed countries. In my country, with the change of residents' lifestyle and dietary structure, the incidence of colorectal cancer is increasing at an annual rate of 4%, and the average annual growth rate is 2 percentage points higher than that of the world.
[0003] The Human Genome Project found that the human body has about 23,000 genes, far fewer...